| Bioactivity | Ralmitaront (RO6889450), a potent and orally active partial agonist of the trace amine-associated receptor 1 (TAAR1), acts as a neuroleptic agent. Ralmitaront can be used for the research of neuro-related diseases, such as schizophrenia (SCZ), schizoaffective disorder, and negative symptoms[1]. | ||||||||||||
| Name | Ralmitaront | ||||||||||||
| CAS | 2133417-13-5 | ||||||||||||
| Formula | C17H22N4O2 | ||||||||||||
| Molar Mass | 314.38 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Linda S Brady, et al. Redirecting the revolution: new developments in drug development for psychiatry. Expert Opin Drug Discov. 2019 Dec;14(12):1213-1219. |
Ralmitaront
CAS: 2133417-13-5 F: C17H22N4O2 W: 314.38
Ralmitaront (RO6889450), a potent and orally active partial agonist of the trace amine-associated receptor 1 (TAAR1), ac
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.